An announcement from Kintara Therapeutics (KTRA) is now available.
Kintara Therapeutics and TuHURA Biosciences recently shared updates on their corporate and clinical progress and outlined key milestones they anticipate reaching in the near future. However, they also cautioned investors about potential risks, including unexpected costs and the chance of the proposed merger between the companies being terminated, which could affect their business operations and financial stability. While forward-looking statements were provided, Kintara and TuHURA emphasized that these are not guarantees of future performance and actual results may differ, reminding investors that they have no obligation to update any forward-looking statements unless required by law.
Find detailed analytics on KTRA stock on TipRanks’ Stock Analysis page.
